Depreciation in USD of Elevation Oncology, Inc. from 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Elevation Oncology, Inc. quarterly/annual Depreciation history and change rate from 2020 to Q1 2025.
  • Elevation Oncology, Inc. Depreciation for the quarter ending March 31, 2025 was $5K, a 50% decline year-over-year.
  • Elevation Oncology, Inc. annual Depreciation for 2024 was $24K, a 38.5% decline from 2023.
  • Elevation Oncology, Inc. annual Depreciation for 2023 was $39K, a 44.4% increase from 2022.
  • Elevation Oncology, Inc. annual Depreciation for 2022 was $27K, a 50% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Elevation Oncology, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $5K -$5K -50% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q1 2024 $10K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2023 $10K +$6K +150% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $4K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $4K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05

Elevation Oncology, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $24K -$15K -38.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 $39K +$12K +44.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 $27K +$9K +50% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $18K +$3K +20% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $15K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.